The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Minimal interventions to decrease long-term use of benzodiazepines in primary care: a systematic review and meta-analysis
Open accessAbstract
BACKGROUND: Long-term use of benzodiazepines (BZDs) is common. Not only is such use ineffective, but it also has several risks in addition to dependence, and remains a significant problem among the older population. AIM: To systematically review randomised controlled trials that evaluate the effectiveness of minimal interventions to reduce the long-term use of BZDs in primary care. DESIGN AND SETTING: Systematic review and meta-analysis of randomised controlled trials in UK general practices. METHOD: Cochrane Central, MEDLINE, and Embase (1967-2010) were searched for trials of minimal interventions (such as a single letter or one consultation from a GP) for patients in primary care with long-term (>3 months) BZD use. Pooled risk differences were calculated with 95% confidence intervals. RESULTS: From 646 potentially relevant abstracts, three studies (615 patients) met all the inclusion criteria. The pooled risk ratio showed a significant reduction/cessation in BZD consumption in the minimal intervention groups compared to usual care (risk ratio [RR] = 2.04, 95% confidence interval [CI] = 1.5 to 2.8, [corrected] P<0.001; RR = 2.4, 95% CI = 1.3 to 4.3, P = 0.008) respectively. Two studies also reported a significant proportional reduction in consumption of BZD from baseline to 6 months in intervention groups compared to the control group. The secondary outcome of general health status was measured in two studies; both showed a significant improvement in the intervention group. CONCLUSION: A brief intervention in the form of either a letter or a single consultation by GPs, for long-term users of BZD, is an effective and efficient strategy to decrease or stop their medication, without causing adverse consequences.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Acknowledging problematic use demands an understanding of the impact of the medication over time, skills that should be developed by other interventions, such as psychoeducation or motivational interviewing, as observed in previous studies with this population [11, 47, 48].”
From Dispositional mindfulness, anticipation and abstinence symptoms related to hypnotic dependence among insomniac women who seek treatment: A cross-sectional study (2018) · cites this paper as [47]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Several publications [24,79,80,81,82,83] argue that these brief interventions are very effective, doubling or tripling the abstinence rate achieved in standard care.”
From Cognitive behavioral therapy and acceptance and commitment therapy for the discontinuation of long-term benzodiazepine use in insomnia and anxiety disorders (2021) · cites this paper as [83]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits
Glass, J., Lanctôt, K. L., Herrmann, N., Sproule, B. A., & Busto, U. E. (2005) · BMJ · doi:10.1136/bmj.38623.768588.47 · Cited by 1,161
Morin, C. M., Bastien, C., Guay, B., Radouco-Thomas, M., Leblanc, J., & Vallières, A. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.2.332 · Cited by 348
Strategies for discontinuing long-term benzodiazepine use: Meta-analysis
Voshaar, R. C. O., Couvée, J. E., Van Balkom, A. J. L. M., Mulder, P. G. H., & Zitman, F. G. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.189.3.213 · Cited by 205
Bashir, K., King, M., & Ashworth, M. J. (1994) · Europe PMC (PubMed Central) · Cited by 143
Prevalence of insomnia in elderly general practice attenders and the current treatment modalities
Hohagen, F., Käppler, C. D. O., Schramm, E., Rink, K., Weyerer, S. B., Riemann, D. W., & Berger, T. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb01563.x · Cited by 140
Psychotropic Prescription Use by Community‐Dwelling Elderly in the United States
Aparasu, R. R., Mort, J. R., & Brandt, H. (2003) · Journal of the American Geriatrics Society · doi:10.1034/j.1600-0579.2003.00212.x · Cited by 136
Evaluation of an easy, cost-effective strategy for cutting benzodiazepine use in general practice.
Cormack, M., Sweeney, K., Hughes-Jones, H., & Foot, G. A. (1994) · Europe PMC (PubMed Central) · Cited by 131
Psychotropic Medication and Insomnia Complaints in Two Epidemiological Studies
Ohayon, M. M., & Caulet, M. (1996) · The Canadian Journal of Psychiatry · doi:10.1177/070674379604100711 · Cited by 100
Systematic review of the benzodiazepines.
Priest, R. G. (1980) · BMJ · doi:10.1136/bmj.280.6221.1085-a · Cited by 93
Research works printed but not linked: 1
- Petursson H (1993) in Benzodiazepine dependence, An international perspective on benzodiazepine abuse, ed Hallstrom C (Oxford University Press, Oxford) Chapter 12.
Cited by
Sorted by citations
Benzodiazepine Use in the United States
Olfson, M., King, M., & Schoenbaum, M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1763 · Cited by 786
Treatment of Benzodiazepine Dependence
Soyka, M. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1611832 · Cited by 465
Kurko, T., Saastamoinen, L., Tähkäpää, S.-M., Tuulio‐Henriksson, A., Taiminen, T. J., Tiihonen, J., Airaksinen, M., & Hietala, J. A. (2015) · European Psychiatry · doi:10.1016/j.eurpsy.2015.09.003 · Cited by 283
Polypharmacy Management in Older Patients
Hoel, R. W., Connolly, R. M. G., & Takahashi, P. Y. (2021) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.06.012 · Cited by 235
Swimming Against the Tide: Primary Care Physicians’ Views on Deprescribing in Everyday Practice
Wallis, K. A., Andrews, A., & Henderson, M. (2017) · The Annals of Family Medicine · doi:10.1370/afm.2094 · Cited by 160
Gould, R. L., Coulson, M. C., Patel, N., Highton-Williamson, E., & Howard, R. J. (2014) · British Journal of Psychiatry · doi:10.1192/bjp.bp.113.126003 · Cited by 156
Psychosocial interventions for benzodiazepine harmful use, abuse or dependence
Darker, C. D., Sweeney, B. P., Barry, J. M., Farrell, M. F., & Donnelly-Swift, E. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009652.pub2 · Cited by 142
Ng, B. J., Le Couteur, D. G., & Hilmer, S. N. (2018) · Drugs & Aging · doi:10.1007/s40266-018-0544-4 · Cited by 118
Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review
Pollmann, A. S., Murphy, A. L., Bergman, J. C., & Gardner, D. M. (2015) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-015-0019-8 · Cited by 114
Cadogan, C. A., Ryan, C. A., Francis, J., Gormley, G., Passmore, P., Kerse, N. M., & Hughes, C. M. (2016) · BMC Health Services Research · doi:10.1186/s12913-016-1907-3 · Cited by 96
Simonsmeier, B. A., Flaig, M., Simacek, T., & Schneider, M. (2022) · Health Psychology Review · doi:10.1080/17437199.2021.1967184 · Cited by 81
Lynch, T., Ryan, C. A., Hughes, C. M., Presseau, J., van Allen, Z., Bradley, C., & Cadogan, C. A. (2020) · Addiction · doi:10.1111/add.14981 · Cited by 86
Torres-Bondia, F., de Batlle, J., Galván, L., Buti, M., Barbé, F., & Piñol-Ripoll, G. (2020) · BMC Public Health · doi:10.1186/s12889-020-08984-z · Cited by 69
Fiorillo, A., Dell’Osso, B. M., Albert, U., Atti, A. R., Carmassi, C., Carrà, G., Cosci, F., Vecchio, V. D., Nicola, M. D., Ferrari, S., et al. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s83130 · Cited by 69
Chapoutot, M., Peter-Derex, L., Bastuji, H., Leslie, W., Schoendorff, B., Heinzer, R., Siclari, F., Nicolas, A., Lemoine, P., Higgins, S., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph181910222 · Cited by 59
Discontinuation of psychotropic medication: a synthesis of evidence across medication classes.
Vinkers, C. H., Kupka, R. W., Penninx, B. W., Ruhé, H. G., van Gaalen, J. M., van Haaren, P. C. F., Schellekens, A. F. A., Jauhar, S., Ramos-Quiroga, J. A., Vieta, E., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02445-4 · Cited by 51
Substance use in older HIV-infected patients
Edelman, E. J., Tetrault, J. M., & Fiellin, D. A. (2014) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000069 · Cited by 49
Ballóková, A. L., Peel, N. M., Fialová, D., Scott, I. A., Gray, L., & Hubbard, R. E. (2014) · Drugs & Aging · doi:10.1007/s40266-014-0159-3 · Cited by 50
Fatalities associated with gabapentinoids in England (2004–2020)
Kalk, N. J., Chiu, C., Sadoughi, R., Baho, H., Williams, B. D., Taylor, D. M., & Copeland, C. S. (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15352 · Cited by 47
Patterns of benzodiazepines use in primary care adults with anxiety disorders
Bernard, M.-M. T., Luc, M., Carrier, J., Fournier, L., Duhoux, A., Côté, É., Lessard, O., Gibeault, C., Bocti, C., & Roberge, P. (2018) · Heliyon · doi:10.1016/j.heliyon.2018.e00688 · Cited by 54
Soni, A., Thiyagarajan, A., & Reeve, J. (2023) · Addiction · doi:10.1111/add.15997 · Cited by 41
Madruga, C. S., Paim, T. L., Alves, H. N. P., Miguel, A. C., Massaro, L. T. S., Caetano, R., & Laranjeira, R. (2018) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2018-0088 · Cited by 40
Did the new French pay-for-performance system modify benzodiazepine prescribing practices?
Rat, C., Penhouet, G., Gaultier, A., Chaslerie, A., Pivette, J., Nguyen, J., & Victorri‐Vigneau, C. (2014) · BMC Health Services Research · doi:10.1186/1472-6963-14-301 · Cited by 42
Lukačišinová, A., Fialová, D., Peel, N. M., Hubbard, R. E., Brkic, J., Onder, G., Topinková, E., Gindin, J., Shochat, T., Gray, L., et al. (2021) · BMC Geriatrics · doi:10.1186/s12877-021-02213-x · Cited by 35
Geriatric Consultation Reduces High-risk Medication Usage at Discharge in Elderly Trauma Patients
Sharma, J., Parulekar, M. S., Stewart, P. J., Blatt, M., Zielonka, T., Nyirenda, T. L., Rogers, C., & Tank, L. (2018) · Cureus · doi:10.7759/cureus.3649 · Cited by 35
Prescribing benzodiazepines in general practice
Kennedy, K. M., & O’Riordan, J. (2019) · British Journal of General Practice · doi:10.3399/bjgp19x701753 · Cited by 35
Canadian Guidelines on Benzodiazepine Receptor Agonist Use Disorder Among Older Adults
Conn, D. K., Hogan, D. B., Amdam, L., Cassidy, K.-L., Cordell, P., Frank, C., Gardner, D., Goldhar, M., Ho, J. M.-W., Kitamura, C., et al. (2020) · Canadian Geriatrics Journal · doi:10.5770/cgj.23.419 · Cited by 32
Clinical management of withdrawal from benzodiazepine anxiolytic and hypnotic medications
Baldwin, D. S. (2022) · Addiction · doi:10.1111/add.15695 · Cited by 28
Degenhardt, L. J., Stockings, E., Strang, J., Marsden, J., & Hall, W. (2016) · World Bank, Washington, DC eBooks · doi:10.1596/978-1-4648-0426-7_ch6 · Cited by 26
López‐Pelayo, H., Coma, A. V., Gual, A., Zara, C., & Lligoña, A. (2019) · European Addiction Research · doi:10.1159/000502518 · Cited by 23
Wallis, K. A., & Tuckey, R. (2017) · Journal of Primary Health Care · doi:10.1071/hc17018 · Cited by 22
Electroacupuncture for tapering off long-term benzodiazepine use: A randomized controlled trial
Yeung, W., Chung, K., Zhang, Z.-J., Zhang, S., Chan, W. C., Ng, R. M.-K., Chan, C. L.-W., Ho, L., Yu, B. Y., Chau, J. C.-S., et al. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.11.015 · Cited by 22
Wallis, K. A., Elley, C. R., Lee, A. C.-L., Moyes, S. A., & Kerse, N. M. (2018) · JMIR Research Protocols · doi:10.2196/resprot.9839 · Cited by 20
Mokhar, A., Topp, J., Härter, M. C., Schulz, H., Kühn, S., Verthein, U., & Dirmaier, J. (2018) · PeerJ · doi:10.7717/peerj.5535 · Cited by 20
Role of the prescriber in supporting patients to discontinue benzodiazepines: a qualitative study
Oldenhof, E., Mason, T., Anderson‐Wurf, J., & Staiger, P. K. (2021) · British Journal of General Practice · doi:10.3399/bjgp.2020.1062 · Cited by 21
Discontinuation of chronic benzodiazepine use in primary care: a nonrandomized intervention
Fernandes, M., Neves, I., Oliveira, J., Santos, O., Aguiar, P. M. V., Atalaia, P., Matos, F., Freitas, M. C. D. N. B., Alvim, A., & Maria, V. A. J. (2021) · Family Practice · doi:10.1093/fampra/cmab143 · Cited by 22
NSAID Use after Bariatric Surgery: a Randomized Controlled Intervention Study
Yska, J. P., Gertsen, S., Flapper, G., Emous, M., Wilffert, B., & van Roon, E. N. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2218-9 · Cited by 19
Fulone, I., Silva, M. T., & Lopes, L. C. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-018956 · Cited by 19
Markusse, I. M., Akdemir, G., Huizinga, T. W. J., & Allaart, C. F. (2014) · Clinical Rheumatology · doi:10.1007/s10067-014-2500-y · Cited by 16
Moss, B. G., & Yeaton, W. H. (2015) · Evaluation Review · doi:10.1177/0193841x15610192 · Cited by 16
Mokhar, A., Kühn, S., Topp, J., Dirmaier, J., Härter, M. C., & Verthein, U. (2019) · BJGP Open · doi:10.3399/bjgpopen18x101626 · Cited by 14
Benzocarta: intervención mínima para la desprescripción de benzodiacepinas en pacientes con insomnio
Bueno, M. B., Artaza, E. R. D. V., Uría, J. F., & Iturbe, A. G. (2019) · Gaceta Sanitaria · doi:10.1016/j.gaceta.2019.06.012 · Cited by 14
de Barros, V. V., Opaleye, E. S., Demarzo, M., Curado, D. F., Bowen, S. W., Hachul, H., & Noto, A. R. (2021) · International Journal of Behavioral Medicine · doi:10.1007/s12529-021-10002-4 · Cited by 12
Currow, D. C., & Agar, M. R. (2020) · Drugs & Aging · doi:10.1007/s40266-020-00756-z · Cited by 13
Marković, S. Z., Jovanović, N. I. D., Sedić, B., Vuković, M., Okjan, J. J., Dimitrijević, I., Trikos, L., Mojović, M., & Kastratović, D. A. (2019) · PubMed · Cited by 12
Benzodiazepine usage and patient preference for alternative therapies: A descriptive study
Sake, F., WONG, K. K. H., Bartlett, D. J., & Saini, B. (2019) · Health Science Reports · doi:10.1002/hsr2.116 · Cited by 11
Barros, V. V., Opaleye, E. S., Demarzo, M., Bowen, S., Curado, D. F., Hachul, H., & Noto, A. R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194035 · Cited by 9
Suchtpotenzial und andere Risiken von Benzodiazepinen und Z-Drugs im Alter
Wolter, D. K. (2017) · SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice · doi:10.1024/0939-5911/a000474 · Cited by 9
Nordfjærn, T. (2013) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2316 · Cited by 9
Prescribing safety: the case of inappropriate medicines
Payne, R. (2011) · British Journal of General Practice · doi:10.3399/bjgp11x593730 · Cited by 9
Cadogan, C. A., & Ryder, S. A. (2015) · International Journal of Pharmacy Practice · doi:10.1111/ijpp.12182 · Cited by 8
Benzodiazepine Withdrawal: Clinical Aspects
Wright, S. L. (2020) · The Benzodiazepines Crisis · doi:10.1093/med/9780197517277.003.0008 · Cited by 7
Coteur, K., Nuland, M. V., Vanmeerbeek, M., Henrard, G., Anthierens, S., den Broeck, K. V., Sutter, A. D., Creupelandt, H., Devroey, D., Overmeire, R. V., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-033688 · Cited by 7
Prescribing and facilitating withdrawal from benzodiazepines in primary health care
Oliveira, J., Neves, I., Fernandes, M., Santos, O., & Maria, V. A. J. (2019) · Revista Portuguesa de Clínica Geral · doi:10.32385/rpmgf.v35i4.12239 · Cited by 7
Deprescribing: An umbrella review
Japelj, N., Horvat, N., Knez, L., & Kos, M. (2024) · Acta Pharmaceutica · doi:10.2478/acph-2024-0011 · Cited by 7
Verordnung von Benzodiazepinen und Z-Drugs in hausärztlichen Praxen – eine Querschnittanalyse
Moßhammer, D., Haumann, H., Muche, R., Scheub, D., Joos, S., & Laux, G. (2017) · Das Gesundheitswesen · doi:10.1055/s-0043-104694 · Cited by 6
Carrier, J., Roberge, P., Courteau, J., & Vanasse, A. (2016) · PubMed Central · Cited by 6
Stratégies de sevrage de benzodiazépines en ambulatoire. Revue de la littérature
Naccache, F., & Vorspan, F. (2018) · La Presse Médicale · doi:10.1016/j.lpm.2018.10.007 · Cited by 7
Weleff, J., Anand, A., Squeri, M., Sieke, R., Thompson, N. R., & Barnett, B. S. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2023.2191610 · Cited by 6
Benzodiazepine and Nonbenzodiazepine Hypnotics (Z-Drugs): The Other Epidemic
Umbricht, A., & Vélez, M. L. (2020) · Springer eBooks · doi:10.1007/978-3-030-36391-8_11 · Cited by 5
Anxiolytics: Misuse, Dependence, and Withdrawal Syndromes
Tang, V. M., & Davies, S. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_405 · Cited by 4
Therapie der Benzodiazepinabhängigkeit
Soyka, M., & München, B. (2019) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/a-0836-7514 · Cited by 5
Bischof, G., Otto, C., Bischof, A., & Rumpf, H. (2020) · Suchttherapie · doi:10.1055/a-1128-5050 · Cited by 4
Prescription Drug Abuse: Risks and Prevention
Bramness, J. G. (2014) · Springer eBooks · doi:10.1007/978-88-470-5322-9_29 · Cited by 4
Duarte-Anselmi, G., Pousada, M., Gómez‐Zúñiga, B., & Armayones, M. (2026) · Implementation Science Communications · doi:10.1186/s43058-026-00879-1 · Cited by 3
Environmentally conscious psychopharmacotherapy: Practice recommendations for psychiatrists
Luykx, J. J., Moermond, C., Page, L., Lertxundi, U., & Vinkers, C. H. (2024) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2024.10.003 · Cited by 3
Chapoutot, M., Meloni, F., Peter‐Derex, L., Bastuji, H., Leslie, W., Schoendorff, B., Heinzer, R. C., Nicolas, A., Higgins, S., Bourgeois, A., et al. (2025) · Journal of Behavioral and Cognitive Therapy · doi:10.1016/j.jbct.2025.100533 · Cited by 4
Missbrauch und Abhängigkeit von Benzodiazepinen und Z-Drugs
Soyka, M. (2021) · Nervenheilkunde · doi:10.1055/a-1523-5718 · Cited by 3
Artaza, E. R. D. V., Bueno, M. B., Uría, J. F., & Iturbe, A. G. (2021) · Atención Primaria · doi:10.1016/j.aprim.2021.102191 · Cited by 3
Soyka, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00033-5 · Cited by 2
Afbouwen van chronisch benzodiazepinegebruik
Klaasen, G., Helsen, C., Klaasen, B., & Nuland, M. V. (2015) · Huisarts Nu · doi:10.1007/s40954-015-0079-4 · Cited by 2
INTERVENÇÕES NO USO PROLONGADO DE BENZODIAZEPÍNICOS: UMA REVISÃO.
de Carvalho, M. R. F., Rodrigues, E. T., & Golzio, A. M. F. D. O. (2016) · Revista Saúde & Ciência Online · doi:10.35572/rsc.v5i2.366 · Cited by 2
López, I. F., Lima, A. O. D. L., Gutiérrez‐Valencia, A., Bermúdez, E. G., Martín, F. A., Morente, A. G.-D., Fernández, M. D. M., Cañete, Y. S., & Bermúdez‐Tamayo, C. (2025) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2025.100666 · Cited by 1
O'Hara‐Veintimilla, K., Páez‐García, S., Ramírez-Triana, J., Torres-Tello, K., Forero, P. R. V., & Borda, M. G. (2026) · Age and Ageing · doi:10.1093/ageing/afag112 · Cited by 3
Tiltak mot misbruk av vanedannende midler
Bramness, J. G. (2012) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.12.0093 · Cited by 1
Knowledge regarding Proper Use Guidelines for Benzodiazepines
Inada, K. (2015) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.15-00228-2 · Cited by 1
Take a multifaceted stepwise approach when deprescribing benzodiazepines in older patients
Writers, A. M. (2018) · Drugs & Therapy Perspectives · doi:10.1007/s40267-018-0578-z · Cited by 1
Castelpietra, G., Balestrieri, M., Brusaferro, S., & Arnoldo, L. (2022) · Epidemiology Biostatistics and Public Health · doi:10.2427/13157 · Cited by 1
Bongiorno, P. B. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-43044-9.00142-4 · Cited by 2
Community‐based counselling for benzodiazepine withdrawal: A mixed‐methods study of client outcomes
Wurf, G., & O’Neal, P. (2022) · Counselling and Psychotherapy Research · doi:10.1002/capr.12547 · Cited by 1
Effect of a short video on patients’ motivation for dose reduction or cessation of hypnotics
Amagai, M., Ozone, M., Utsumi, T., Hotchi, A., Iwashita, M., Yamadera, W., & Shigeta, M. (2023) · Sleep and Biological Rhythms · doi:10.1007/s41105-023-00446-4 · Cited by 1
Baldwin, D. S., Impey, B., & Masdrakis, V. G. (2024) · Cambridge University Press eBooks · doi:10.1017/9781911623861.014 · Cited by 2
Dispensación de benzodiacepinas y análogos en farmacias comunitarias de Valladolid
Sevillano, L. G., & Blanco, C. S. (2013) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1
Interventions for benzodiazepine withdrawal: Perceptions of benzodiazepine counsellors
Wurf, G., & Swing, A. (2021) · Counselling and Psychotherapy Research · doi:10.1002/capr.12453 · Cited by 1
Exploring optimal pharmacotherapy after bariatric surgery: where two worlds meet
Yska, J. P. (2017) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 1
Therapie der Benzodiazepinabhängigkeit
Soyka, M. (2018) · PSYCH up2date · doi:10.1055/a-0525-5277 · Cited by 1
GABAA receptor subunit-related neuroanatomical substrates for attenuation of anxiety
Hellsten, K. (2015) · Työväentutkimus Vuosikirja
Употреба на бензодијазепини кај пациенти на метадонски третман
Петрушевска, Т. (2015) · Macedonian Medical Electronic Journal · doi:10.3889/mmej.2015.50006
Mye søvnplager – for mye hypnotika
Øyane, N., & Steihaug, O. M. (2013) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.13.1178
Abhängigkeit von Hypnotika und Tranquilizern
Soyka, M. (2015) · DNP - Der Neurologe und Psychiater · doi:10.1007/s15202-015-0843-0
Benzodiazepine Withdrawal in the Elderly: A Practical Approach
Mallet, L. (2016) · Springer eBooks · doi:10.1007/978-3-319-32304-6_18
Elaboration d'un outil de formation en ligne de type
Coispeau, É. (2016)
Aigner, M. (2016) · psychopraxis neuropraxis · doi:10.1007/s00739-016-0336-8
Predicting chronic benzodiazepine use in adults with depressive disorder
Carrier, J., Roberge, P., Courteau, J., & Vanasse, A. (2016) · Canadian Family Physician
Managing benzodiazepine dependence
Cosh, A., & Carslaw, H. (2017) · InnovAiT Education and inspiration for general practice · doi:10.1177/1755738017715275
4 Chronisch slaapmiddelengebruik
Jong, J. K.-D. (2016) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-1082-1_4
Prescription Drug Abuse: Risks, Diversion, and Prevention
Bramness, J. G. (2020) · Springer eBooks · doi:10.1007/978-3-030-36391-8_22
Metadata
- Authors
- Mugunthan, K., McGuire, T., & Glasziou, P.
- Affiliations
- Bond University (AU)
- Venue
- British Journal of General Practice
- Published
- 2011-09
- Volume
- 61
- Issue
- 590
- Pages
- e573-e578
- ISSN
- 0960-1643 (ISSN-L)
- 1478-5242
- PMC
- PMC3162180
- OpenAlex
- W2153607529
- Cited by
- 123
- References
- 20
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 7 · 2023: 2 · 2022: 6 · 2021: 15 · 2020: 11 · 2019: 9 · 2018: 19 · 2017: 8 · 2016: 11 · 2015: 12 · 2014: 10 · 2013: 4 · 2012: 1
- FWCI
- 0.42
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- British Journal of General Practice (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Bond University Research Portal (Bond University) (submittedVersion, other-oa)
- e-publications@bond (Bond University) (submittedVersion)
- Funders
- Bond University
- National Health and Medical Research Council (527500)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- benzodiazepines, long-term benzodiazepine use, brief intervention, primary care, general practice, patient letters, health status, older adults, benzodiazepine dependence
- MeSH terms
- Adolescent, Adult, Aged, Anxiety Disorders, Benzodiazepines, Communication, Female, United Kingdom, Humans, Long-Term Care, Male, Middle Aged, Patient Education as Topic, Physician-Patient Relations, Referral and Consultation, Risk Factors, Randomized Controlled Trials as Topic, Young Adult, General Practice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review